C difficile
Journal review: Emergence and Spread of C difficile Isolates With reduced Fidaxomicin Susceptibilti in an Acute Care Hospital.
2 March 2025
Sarah N Redmond et al, Emergence and Spread of Clostridioides difficile Isolates With Reduced Fidaxomicin Susceptibility in an Acute Care Hospital, Clinical Infectious Diseases, 2025;, ciaf028, https://doi.org/10.1093/cid/ciaf028 Introduction & Background: Methods: Key Findings: Discussion & Implications: Some points to consider
C difficile Infection guideline – comparison between NICE 2021 and IDSA 2021
16 September 2023
What does NICE guideline 2021 say about assessing and managing C difficile infection? Comparison between NICE 2021 guideline and IDSA 2021 update IDSA/SHEA focussed update 2021 NICE 2021 1st episode of CDAD -1st line Fidaxomicin 200 mg BO PO 10 days Vancomycin 125 mg QDS PO 10 days 1st episode of CDAD - 2nd line […]